|
Summary of Contents
(See Prospectus for Full Contents)
Executive Summary
The Pain Management Market Opportunity
Evolution in Pain Management Guidelines
Regional Factors in Pain Management Practice
Pain
Management Demand Drivers
Competitive Landscape
Factors Limiting Growth
Inhalation Technology, Platforms and Design Factors
Drug
Formulations
Formulation Technologies
Excipients and Release Profiles
Oral
Inhalation Device Design Factors
Dry Powder Inhalers
Metered Dose Inhalers
Nebulizers
Aerosolized Discrete Liquid dose
Nasal
Inhalation
Nasal Delivery Pharmacokinetics
Nasal Device Characteristics
Performance Factors
Bioavailability
Dose Reproducibility
Active Compound Stability
Inhaled Pain Management Drugs - Analysis and Forecasts
Approved Drugs
AstraZeneca
GlaxoSmithKline
Mylan
Novex
Roxane
Valeant
Development-Stage Drugs
Butorphanols
Fentanyls
Dihydroergotamines
Morphines
Penthrox
Perchlorperazine
Triptans
Market Factors
Usability and Patient Preferences
Regulatory Issues
Patient Compliance
The
Role of CMOs/CSOs
Company Profiles
|